Skip to main content
. Author manuscript; available in PMC: 2014 Nov 13.
Published in final edited form as: Gynecol Oncol. 2013 Jul 6;131(1):42–45. doi: 10.1016/j.ygyno.2013.06.034

Table 3.

Five-year survival stratified by stage and histology.

Carcinosarcoma Serous
Stage I 65.2% (58.0-71.4%) 80.6% (78.9-82.2%)
Stage II 34.6% (27.2-42.0%) 61.7% (59.1-64.2%)
Stage IIIC 18.2% (14.5-22.4%) 33.3% (32.1-34.5%)
Stage IV 11.2% (8.1-14.9%) 20.3% (19.2-21.3%)